ABSTRACT: Mytilus edulis develop progressive and fatal hemocytic neoplasia. We have generated monoclonal antibodies using neoplastic hemocytes from highly infected individuals collected from Puget Sound in Washington State (USA). Twenty-seven monoclonal antibodies against neoplastie cell antigens were obtained. Specificity of 2 purified antibodies, 14F1 and 16G10, was demonstrated by immunofluorescence when incubated with neoplastie hemocytes, whereas these antibodies did not react with normal cells. This specificity was confirmed by immunogold labelling and electron microscopie visualization. The technique permitted localization of the epitopes recognized by the monoclonal antibodies on the plasma membrane. These monoclonal antibodies are suitable reagents for establishment of immunoassays for diagnosis and quantification of hernie neoplasia in the mussel.
INTRODUCTION
Hernie proliferative disorders have been reported from at least 15 species of bivalve molluscs around the world (Farley & Sparks 1969 , Brown et al. 1977 , Balouet et al. 1983 , Twomey & Mulcahy 1984 , Peters 1989 . The condition has been intensively studied in both the clam Mya arenaria (Cooper et al. 1982 ) and the mussel Mytilus edulis, in which it is considered to be a neoplastic process (Elston et al. 1988a) . Hemocytic neoplasia (HCN) in M. arenaria is transmissible and results from a retrovirus infection (Oprandy et al. 1981) whieh is indu cible by bromodeoxyuridine (Oprandy & Chang 1983) . In M. edulis, the condition is characterized by the proliferation of enlarged circulating hemocytes with a high nucleus-to-cytoplasm ratio. Mitotie figures are common in affected cells which appear to replace both normal hemocytes and other tissues in the terminal stage of the disease. An important recent observation was that, although hernie neoplasia is progressive and fatal in most M. edulis from a specifie field population, a certain proportion of individuals undergo remission of the disease (Elston et al. 1988a ). Furthermore, Elston et al. (1988a) presented histologieal evidence © Inter-Research/Printed in Germany indicating that remission resulted from the recognition of neoplastic cells. by morphologieally normal ho st hemocytes. The condition is also transplantable with whole cells and transmissible with cell-free homogenates but the etiologic agent remains unknown (Elston et al. 1988b ). Monoclonal antibodies have been used in vertebrate oncology to characterize specifie cellular antigens as well as for the establishment of immunoassays to diagnose and quantify cancer and other diseases (Delsol et al. 1989 ). Moreover, they are useful tools for studying the origin of neoplastic cells. In this paper, we report the preparation of monoclonal antibodies specifie for neoplastie hemocytes in M. edulis.
MATERIAL AND METHODS
Organisms. Infected mussels were obtained from Puget Sound in Washington State (USA). Healthy individuals were collected from Marennes-Oléron Basin (France). Mussels were identified as Mytilus edulis by morphologie features. However, recent population studies utilizing isozyme analyses suggest that previ-ously accepted species designations are not universally accepted (McDonald & Koehn 1988) .
Hemocytes. Mussels were bled through the posterior adductor muscle. Blood samples (500 to 1500 [,LI) were withdrawn into separate syringes through 23 gauge needles. A drop of hemolymph from each sample was immediately deposited on a glass slide and examined using inverted differential interference contrast microscopy. Neoplastic cells were identified by their relatively large size, and by failure to spread and attach to glass microscope slides. Whole hemolymph samples were stored at -20 oc. Immunization proto cols.
Active immunization: Four Balb/c mice were immunized by initial intravenous injections (300 [,LI) of neoplastic cell suspensions (1.2 x 10 7 cells) diluted with 2 parts of sterile distilled water to 1 part of cell suspension in order to ob tain a solution which was isosmotic to mouse serum. Subsequently, 4 similar injections were made at 2 wk intervals.
Three weeks after the last immunization, serum titers were estimated for aIl mice using normal and neoplastic cells by the Radio Immunological Assay method (RIA) described below.
Passive immunization: Specific immun e sera against normal hemocytes were prepared by making 4 successive intravenous or intraperitoneal inoculations of normal hemocyte suspensions (300 [,LI) containing ca 300 000 cells each. These injections were made at 3 d intervals. One week after the la st booster, mice were exsanguinated in order to recover the serum. These sera were pooled and incubated for 2 h (37 O C) with neoplastic hemolymph which had been subjected to one freezing and thawing cycle in order to expose both internaI and external epitopes of the cells. After subsequent centrifugation (4000 g, 30 min), the pellet was resuspended in 3 ml of 0.2 M NaCl. With this suspension, 4 intravenous inoculations (300 [,LI) were performed on mice at 3 d intervals with the la st injection made 1 mo before fusion.
Fusion protocol. For the 2 mice selected by the RIA method (see below), a la st intraperitoneal booster (10 7 cells in 300 [,LI) was made 3 d before fusion. The myeloma cell line P3-X63-Ag653 (653) was cultivated in RPMI 1640 (Gibco Laboratories) containing 10 % heat-inactivated fetal calf serum (FCS) and 0.2 M glutamine (complete RPMI). Before the fusion, these cells were cultivated in complete RPMI supplemented by 0.13 mM azaguanine, which is a lethal analog of hypoxanthine, in order to eliminate possible HGPRT+ mutants in the culture. Spleen cells were fused with the myeloma cellline by a method adapted from French et al. (1986) . Splenocytes and myeloma cells were washed and suspended in a serum-free medium (RPMI 1640). Two fusions, A and B, were performed corresponding to mice respectively immunized according to active and passive protocols. Splenocytes from mouse A (1.13 x 10 8 ) and from mouse B (1.56 x 10 8 ) were centrifuged with myeloma cells (ratio 5 to 1) (200 g, 10 min, room temperature) . Subsequently, 1 ml of 40 % polyethylene-glycol 1540 (Rie deI de Haen AG, Seelze, Hannover, Germany) was added to the cell pellet dropwise over 30 s with gentle stirring. After 1 min at 37 oC , the cells were pelleted by centrifugation (200 g, 90 s) and incubated for another 2 min at 37 oc. The pellet was then diluted to 15 ml by addition of serum-free medium (the first 6 ml were added over 5 min).
Cells were centrifuged for 10 min at 150 g, resuspended in the medium containing 10 % fetal calf serum in order to obtain 1.5 x 10 6 cells ml-1 and distributed (0 .1 ml well-1 ) into micro culture plates containing macrophages as feeder cells (1 to 2 x 10 4 Balb/c peritoneal exudate cells (0.2 ml)-l well-1 ). Nine plates were prepared for Fusion A and 12 for Fusion B. These conditions were considered a pre-cloning step . One day after fusion, hybridomas were selected in HAT medium Hybridoma screening procedure. Two screening tests were simultaneously used for each precloned hybridoma culture supernatant in order to estimate their relative activity against normal hemocytes (control test) and against neoplastic hemocytes (positive test). For each type of screening test, either normal or ab normal hemocytes (50 000 cells well-1 ) were seeded in microtiter plates (Millititer type GV, Millipore). These cells were concentrated and adsorbed by vacuum filtration on the porous membrane (0.22 [,Lm) which constituted the bottom of the weIl. After a wash with 0.5 M NaCI and vacuum filtration, the plates were dried at 37 oc.
The hybridoma culture supernatants (50 [,LI) w ere tested using a RIA assay. They were placed into each weIl for incubation (1 h, ambient temperature). After 5 washes (PBS), a goat anti-mouse IgG (Diagnostic Pasteur) , labelled with 1 125 by oxidation with chloramine T (Butt 1984) and diluted in PBS with 0.5 % BSA (Bovine Serum Albumin) to 2 x 10 6 cpm ml-\ was incubated in each weIl (100 [,LI well-l, 1 h, ambient temperature). Following incubation and 5 washes with PBS containing 0.5 % Tween 20, the membranes of each weIl w ere removed and the radioactivity was measured with a gamma counter.
Cloning procedure. The selected hybridomas w ere cloned using the limiting dilution method. The super-natants were then tested using an enzymatie immunoassay (ELISA). Initial steps were the same as those p reviously deseribed. Radiolabelled goat antimouse IgG was replaeed by alkaline phosphatase eonjugate (Biosys), diluted (114000) in immunofluorescenee b uffer (Diagnostic Pasteur). Following 7 washes with 0. 2 M NaCl eontaining 0.05 % Tween 20, the substrate solution (1 mg nitrophenylphosphate ml-1 diethanolamine, 5 % in distilled water, pH 9.8) was ineubated at 37 oC for 1 h (200!k1 well-1 ). Samples (100 !kl) were finally taken from eaeh weIl and plaeed in polystyrene mieroplate wells in order to measure their optieal densities at 405 nm using a mieroplate speetrophotometer. Production and purification oi MABs. The cloned selected hybridomas (3 to 5 x 10 6 cells) were injected intraperitoneally into Balb/c mice which had been injected 15 d before with 500 !kl of pristane. The ascitic fluids, which were positive 10 to 28 d after injection of the cells, were clarified by centrifugation and the monoclonal antibodies contained therein were purified by affinity chromatography with protein A-sepharose (Pharmacia). Isotypes of hybridoma culture supernatant antibodies were identified by the mouse monoclonal antibody isotyping kit (Amersham) . Indirect immunoîluorescence. the specificity of each selected monoclonal antibody was tested by indirect immunofluorescence. For this purpose, hemolymph smears were prepared, air-dried and fixed by immersion in acetone (10 min). They could be used immediately or stored at -20 oc. The assays were performed by overlaying the slides with a monoclonal antibody solution (specific or control) used at a final concentration of 25 !kg ml-1 after dilution in immunofluo res cence buffer (Diagnostic Pasteur). After a 15 min incubation period at ambient temperature in a moist chamb er, the slides were washed 3 times with the previous buffer. They were then overlayed with FITCconjugated goat anti-mouse Ig serum (Diagnostic Pasteur), diluted in the same buffer (1/100) containing 1 % Evans-blue for 30 min at room temperature. The slides were examined for bright green fluorescent cells that were morphologically consistent with neoplastic hemocytes. Control antigens consisted of hemolymph smears prepared from healthy mussels. Control antibody p reparations consisted in monoclonal antibodies against an oyster parasite Bonamia ostreae (Rogier et al. in p ress).
Preembedding ultra structural immunohistochemistry.
Fixation: Hemocytes were fixed with 4 % paraformaldehyde in 1 M Sorensen buffer, pH 7.4, for 60 min at 4 oc. They were then washed 3 times in phosphatebuffere d saline, pH 7.4 (PBS: 8 g NaCl, 0.2 g KCl, 1.44 g Na2HP04-2H20, 0.23 g NaH 2 P0 4 , 1000 ml distilled w ater), containing 0.02 M glycine to quench free aldehyde groups (Slot et al. in press Electron microscopy: Cells were post-fixed in 1 % osmium tetroxide to achieve adequate membrane preservation. After an additional wash in cacodylate-NaCl buffer, they were pre-embedded in agarose and processed for dehydration and embedding in Epon 812. Ultrathin sections were obtained using a diamond knife and double contrasted with aqueous uranyl acetate and lead citrate. The grids were viewed under a Jeol 1200 CX transmission electron microscope.
RESULTS

Immunization oi mice
Following active or passive immunization (Springer 1983) , the specificity of serum of each mouse was evaluated by the RIA method. These sera contained antibodies against both normal and neoplastic hemocytes . Regardless of which immunization proto col was used, all tested mice showed a greater immunoreactivity against normal cells than against neoplastic hemocytes (data not shown). However, one mouse (A) actively immunized, exhibited an immunologic activity against ab normal hemocytes at least comparable to the one against normal cells. Another mouse (B) immunized according to the passive protocol, was also retained for fusion due to its high reactivity against both normal and neoplastic hemocytes (Fig. 1) .
Hybridoma selection
The immunofluorescence pattern obtained with polyclonal antibodies had previously revealed the presence of a majority of common antigens on both normal Based on a difference of 3000 cpm between the signaIs obtained against these 2 kinds of normal or tumor antigens, 27 hybridomas were retained. A variability in the reactivity of hybridoma culture supernatants against transformed hemocytes is shown in Fig. 2 b ut for clearest representation, only 10 of them were selected for this figure. Most of the monoclonal antibodies specifie for neoplastic hemocytes were obtained from Fusion B, that is after passive immunization.
Cloning
Comparison of the ELISA and RIA methods is given in Table 1 . Although the ELISA method was less sensitive than the RIA method, it detected hybridomas showing a high activity against neoplastic cells and was thus selected for cloning in order to avoid use of radioactive isotopes. Two hybridomas, 14Fl an d 16Gl0, were selected and cloned because they showed the highest specifie activities against ab normal cells (Fig. 2) . Furthermore, when testing reactivity of the monoclonal antibodies after successive hybridoma culture supernatant dilutions, the results indicated a higher affinity of these 2 antibodies for their antigens than the other antibodies (Fig. 3A, B) . Using the double screening ELISA method, 3 and 4 clones, respectively, were selected ( Table 2 ). The monoclonal antibodies of clones 14Fl-5E9 and 16Gl0-5B9 were then produced by the ascitic fluid method, described earlier a n d purified on protein A-sepharose. Their isotopes w ere both determined as IgG 1. 
Specificity of purified antibodies demonstrated by immunofluorescence
Reactivity of each mouse immunserum was tested by immunofluorescence before fusion and has shown no specificity against the neoplastic cens. The monoclonal antibody specificity for neoplastic hemocytes was confirmed by indirect immunofluorescence. These antibodies did not pro duce any fluorescence when incubated with normal hemocytes either from healthy French mus sels or healthy Puget Sound mussels whereas they strongly reacted with neoplastic cens. The bright green fluorescence was localized at the plasma membrane (Fig.4a, b) . Using control monoclonal antibodies, no fluorescence was observed with either normal or abnormal hemocytes.
Localization of the epitopes recognized by the monoclonal antibodies
When ultrathin sections of specifie antibody-PAG labe11ed hemocytes were examine d, observations con- firmed the specificity of 14Fl and 16Gl0 antibodies for neoplastic cens: gold particles were found only on abnormal hemocytes (Fig. 5a, b) . No label was seen on normal cens when present in neoplastic mussels or on healthy hemocytes used as controls. The epitopes recognized by 14Fl and 16Gl0 monoclonal antibodies were located at the plasma ce11 membrane. The gold particles were sparsely distributed on the membrane and the labelling pattern was similar for the 2 antibodies.
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DISCUSSION
The objective of these studies was to ob tain monoclonal antibodies specifie for neoplastic hemocytes. The main problems were the presence of common antigens on normal and abnormal cells and the difficult y in purifying sufficient amounts of specifie proteins. In order to alleviate these problems, a passive immunization procedure, resulting in a masking of normal antigens on neoplastic hemocytes, was used before their inoculation into miee (Springer 1983) . In addition to typieal active immunization, the theoretical advantage of the passive immunization procedure was to enhance the immune response to. ?ost antigens not bound with antibodies, that is, specifie neoplastie antigens. Initially, it appeared that the passive immunization was more efficient since most hybridomas specifie for neoplastic cells were selected after fusion from a mouse immunized according to this proto col. However, it must be pointed out that at fusion day, this mouse also exhibited a high titer of antibodies against normal hemocytes. A second important step concerned the selection of specifie hybridomas. In order to avoid the presence of several hybridomas in the same weIl, precloning, which consisted in seeding a large number of wells, was performed (Paolucci 1983) . Screening was subsequently always performed in parallel on normal and abnormal hemocytes, adsorbed at a constant and identical number on Durapore membranes of Millititer plates (Millipore) (Dao 1985 , Hessian et al. 1989 . This method provides a better inter-weIl reproducibility compared to the more classical method of antigen adsorption on polystyrene plates with poly-L-Iysine (Miosky et al. 1989) .
Immunohistochemical methods, used by other investigators for screening monoclonal antibodies against neoplastic cells in Mytilus arenaria (Reinisch et al. 1983 ), appeared less practical for hybridoma supernatant screening compared to the RIA or ELISA methods. Moreover, alkaline phosphatase was preferred to peroxidase for antibody labelling, in order to prevent non-specifie signaIs which could result from endogenous hemocyte activity (Chagot, 1989) . Using this double screening protocol, hybridoma types were selected according to their specificity against normal and/or neoplastie hemocytes, although only results for hybridomas reacting with the neoplastie hemocytes are reported here.
The exclusive reactivity of purified monoclonal antibodies 14F1 and 16G10 with ab normal hemocytes was confirmed by indirect immunofluorescence. The specifie localization of the recognized neoplastic epitopes on the cytoplasmie membranes by immunogold labelling and electron mieroscopic examination demonstrated another use of the monoclonal antibodies. These antibodies can also be used to study the role of neoplastic epitopes in tumor cell recognition by normal hemocytes, which apparently occurs in mussels Undergoing remission (Elston et al. 1988a) . Such involvement could be analyzed by using hemocyte Primary cultures to look for an inhibition of recognition by normal hemocytes of tumor cells previously incubated with monoclonal antibodies (Mourton 1987 , Chagot 1989 ). These specific antibodies can also be used to identify hematopoietic tissues by histological examination of early infected individuals. Furthermore, monoclonal antibodies can be used to study the transformation process and to characterize oncoproteins. The membrane localization of the epitopes could correspond to growth factor receptors (Deuel 1987) or tyrosine kinases. Isolation of mRNA co ding for oncoproteins from neoplastic hemocytes and utilization of monoclonal antibodies to check their in vitro translation products will be useful in subsequent preparation of cDNA. Finally, a diagnostic method based on the monoclonal antibodies may be more convenient for epizootiological surveys than cytofluorometry (Elston et al. 1990) or immunoperoxidase histology (Smolowitz & Reinisch 1986 ).
